Clinical Trials

Status
Title Intervention Sponsor Status
A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy Aspirin, Omeprazole University of Michigan Rogel Cancer Center Recruiting
Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma Aspirin, Biospecimen Collection, Placebo Administration, Questionnaire Administration, Rectal Biopsy National Cancer Institute (NCI) Active, not recruiting
Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
ASPirin Intervention for the REDuction of Colorectal Cancer Risk Placebo for Aspirin, Aspirin Massachusetts General Hospital Active, not recruiting
Cancer Preventive Vaccine Nous-209 for Lynch Syndrome Patients Adenoviral Tumor-specific Neoantigen Priming Vaccine GAd-209-FSP, Biospecimen Collection, Endoscopic Biopsy, MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP, Questionnaire Administration National Cancer Institute (NCI) Active, not recruiting
CHARM II: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts Ethanol, Normal saline, Paclitaxel + Gemcitabine admixture Milton S. Hershey Medical Center Active, not recruiting
Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia Curcumin, Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment National Cancer Institute (NCI) Active, not recruiting
Defined Green Tea Catechin Extract in Preventing Liver Cancer in Participants With Cirrhosis Biopsy, Biospecimen Collection, Computed Tomography, Defined Green Tea Catechin Extract, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Pharmacological Study, Questionnaire Administration, Ultrasound National Cancer Institute (NCI) Active, not recruiting
DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection Electroporation-Mediated Plasmid DNA Vaccine Therapy, HCV DNA Vaccine INO-8000, Laboratory Biomarker Analysis, Quality-of-Life Assessment, Rocakinogene Sifuplasmid National Cancer Institute (NCI) Active, not recruiting
GCC Agonist Signal in the Small Intestine Biopsy, Biospecimen Collection, Esophagogastroduodenoscopy, Linaclotide, Plecanatide National Cancer Institute (NCI) Recruiting